10 Biotech Stocks to Buy According to Matthew Strobeck’s Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Posts Tagged ‘NASDAQ:XLRN’
5 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Here’s Why You Should Consider Investing in Acceleron Pharma (XLRN)
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Analysts are Raising Price Targets of These 10 Stocks
In this article, we discuss the 10 stocks that analysts are raising price targets of.
Hedge Fund and Insider Trading News: Generation Investment Management, Starboard Value LP, Black-and-White Capital, Marriott International Inc (MAR), Acceleron Pharma Inc (XLRN), and More
Activist investing can be a lonely slog in the Middle East.
Baron Funds: “Acceleron (XLRN) Remains a Top Pick, We Have Not Changed Our Conviction”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Here is What Hedge Funds Think About Acceleron Pharma Inc (XLRN)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is XLRN Stock A Buy or Sell?
We at Insider Monkey have gone over 887 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US.
Is XLRN A Good Stock To Buy According To Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is Acceleron Pharma (XLRN) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Were Hedge Funds Right About Embracing Acceleron Pharma Inc (XLRN)?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are...
Hedge Funds Have Never Been This Bullish On Acceleron Pharma (XLRN)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Make The Right Call On Acceleron Pharma Inc (XLRN) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: Bill Ackman, Graham Capital Management, D1 Capital Partners, Timefolio Asset Management, Box Inc (BOX), Korn Ferry (KFY), and More
Graham Capital Management, the long-running US quant hedge fund manager, is launching its multi-asset diversified quant strategy, the Graham Quant Macro fund, on Lombard Odier...
Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Do Hedge Funds Love Acceleron Pharma Inc (XLRN)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
2019 Review: Top Hedge Fund Stocks vs. Acceleron Pharma Inc (XLRN)
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Is Acceleron Pharma Inc (XLRN) Going to Burn These Hedge Funds?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Here’s What Hedge Funds Think About Acceleron Pharma Inc (XLRN)
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Is Acceleron Pharma Inc (XLRN) A Good Stock To Buy?
Is Acceleron Pharma Inc (NASDAQ:XLRN) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Former CEO of Finish Line Inc. (FINL) Sells Shares as Underperformance Persists; Other Notable Insider Transactions
It is already common knowledge that corporate insiders are savvy long-term-oriented investors, with their purchases beating broader market benchmarks on aggregate.
Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
QVT Financial Reduces Exposure to Healthcare Going Into 2016; Here Are Its Top Stock Picks
QVT Financial is a New York-based long/short equity hedge fund founded by Daniel Gold in 2003. Prior to founding QVT Financial, Mr.
Hedge Funds Are Dumping Acceleron Pharma Inc (XLRN)
It's a little-known fact that stock performance is not evenly distributed (i.e. you don't have a 50/50 chance of picking a market-beating stock).
Foresite Capital Betting It All On These Four Healthcare Stocks
Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held...
Tekmira Pharmaceuticals Corp (TKMR): QVT Financial’s New Holding and Two Other Healthcare Picks
Daniel Gold’s QVT Financial has disclosed a new stake in Tekmira Pharmaceuticals Corp (NASDAQ:TKMR). According to the 13D Form filed with the U.S.
